Diabetes and respiratory diseases as comorbid conditions in COVID-19 patients from Kazakhstan: a retrospective pilot study

Tazhibayeva K. Abdrakhmanova Z. Shensa A. Raushanova A. Sadykova A. Glushkova N. Mamyrbekova S. Zhagiparova Z. Beisbekova A. Linkov F.
2025 PeerJ Inc.

PeerJ
2025

Background. Diabetes and respiratory diseases are prevalent in Central Asia, and their prevention represents an opportunity to increase life expectancy in the region, especially in Kazakhstan. This study aims to analyze trends in the prevalence of diabetes and respiratory diseases as comorbidities in patients with recent COVID-19 infections, based on the information obtained from several clinics in Almaty, Kazakhstan. Methods. This study was conducted as a cross-sectional analysis using de-identified electronic medical records from a multidisciplinary hospital in Almaty, Kazakhstan. Adults hospitalized with laboratory-confirmed COVID-19 during 2021–2022 were included (N D 292; mean age 55 years, range 18–91). Continuous variables were summarized with means and standard deviations, and categorical variables with counts and percentages. Data extraction and statistical analyses were performed in September–December 2023. Results. The mortality rate was higher among patients with pneumonia (16.8%) compared to chronic bronchitis (10.6%). We identified a high level of comorbidity with diabetes (35.3% in the 45–59 age group) and chronic respiratory disease (37.9% in the same group). Discussion. The mortality and comorbidity rates for hospitalized patients with recent COVID-19 infections in Almaty were high in comparison to other middle-income countries. These findings underscore the need for targeted early prevention strategies and public health interventions to address the rising burden of chronic diseases in Kazakhstan, particularly among middle-aged adults.

Central Asia , Diabetes , Disease burden , Kazakhstan , Prevention

Text of the article Перейти на текст статьи

Al-Farabi Kazakh National University, Almaty, Kazakhstan
Duquesne University, Pittsburgh, PA, United States
Kazakh National Medical University Named After S. D. Asfendiyarov, Almaty, Kazakhstan

Al-Farabi Kazakh National University
Duquesne University
Kazakh National Medical University Named After S. D. Asfendiyarov

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026